sefulness of Individualized homoeopathic medicine on Moderate to Severe Allergic Rhinitis: A prospective, non-randomized, open-label, clinical study - NI

All India Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年5月27日

试验速览

暂无简介。

•1. Any other types of chronic rhinitis
•2. History of anaphylactic reactions
•3. Moderate to severe atopic dermatitis
•4. Symptoms of asthma in accordance with the GINA criteria with more than one of the following: (1) occurrence of asthma symptoms more than twice per week, (2) any night waking due to asthma, (3) reliever (beta-2-sympathomimeticdrug) needed more than twice per week, except for reliever taken before exercise, (4) activity limitation due to asthma
•Renal insufficiency (serum creatinine concentration above (0.6–1.4 mg/dl or 50–130 µmol/l) measured within the last 16 weeks;
•Current daily use of topical or systemic corticosteroids;
•Allergen-specific immunotherapy used currently or within the past 3 years;
•Homeopathic therapy used currently or within the past 6 weeks;
•Recent (the past 6 weeks) use of other complementary and integrative medicine treatments for AR
•Alcohol addiction; pregnancy or breastfeeding;
•Serious acute or chronic organic diseases or serious mental disorder;
•Severely immuno-compromised patients for example patients with history of HIV infection, patients with solid organ transplantation or bone marrow transplantation, patients receiving chemotherapy/radiotherapy, patients with primary immunodeficiency.
•Have cardiovascular disease or severe haematological illness like Sickle cell disease.

发起方